Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy

Neurology. 1995 Sep;45(9):1764-5. doi: 10.1212/wnl.45.9.1764.

Abstract

We examined apolipoprotein E (ApoE) immunoreactivity and allele frequency in 12 autopsied cases of progressive supranuclear palsy (PSP), a neurodegenerative disease characterized by diffuse neurofibrillary tangle (NFT) formation without beta-amyloid deposits. In spite of the ApoE immunoreactivity associated with NFTs, in PSP the ApoE allele frequency was comparable with that of age-matched normal controls. This suggests that in Alzheimer's disease the increased frequency of ApoE epsilon 4 does not influence neurofibrillary degeneration, but is probably linked to beta-amyloid deposition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Amyloid beta-Peptides / analysis
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Gene Frequency
  • Genotype
  • Humans
  • Immunohistochemistry
  • Neurofibrillary Tangles / pathology
  • Pons / pathology
  • Supranuclear Palsy, Progressive / genetics*
  • Supranuclear Palsy, Progressive / pathology

Substances

  • Amyloid beta-Peptides
  • Apolipoprotein E4
  • Apolipoproteins E

Grants and funding